Folgen
Aaron Glieberman, PhD
Aaron Glieberman, PhD
Director of Platform Development, MelliCell, Inc.
Bestätigte E-Mail-Adresse bei alumni.brown.edu
Titel
Zitiert von
Zitiert von
Jahr
Measuring the activity of BioBrick promoters using an in vivo reference standard
JR Kelly, AJ Rubin, JH Davis, CM Ajo-Franklin, J Cumbers, MJ Czar, ...
Journal of biological engineering 3 (1), 1-13, 2009
4912009
Synchronized stimulation and continuous insulin sensing in a microfluidic human Islet on a Chip designed for scalable manufacturing
AL Glieberman, BD Pope, JF Zimmerman, Q Liu, JP Ferrier, JHR Kenty, ...
Lab on a Chip 19 (18), 2993-3010, 2019
812019
Fattening chips: hypertrophy, feeding, and fasting of human white adipocytes in vitro
BD Pope, CR Warren, MO Dahl, CV Pizza, DE Henze, NR Sinatra, ...
Lab on a Chip 20 (22), 4152-4165, 2020
122020
Building Biomimetic Potency Tests for Islet Transplantation
AL Glieberman, BD Pope, DA Melton, KK Parker
Diabetes 70 (2), 347-363, 2021
102021
Cartridge-based system for long term culture of cell clusters
AR Gannon, AL Glieberman, KK Parker, BD Pope, KL Shores, NR Sinatra
US Patent 11,384,328, 2022
2022
MICROFLUIDIC TRAPPING CHIP AND USES THEREOF FOR CULTURE AND ASSAY OF CELL CLUSTERS AND OBJECTS
AL Glieberman, JP Ferrier, JF Zimmerman, KK Parker
US Patent App. 16/756,896, 2021
2021
In Vitro Models for the Pancreatic Islet Using Dynamic Secretion Sensing and Mechanical Stimulation
AL Glieberman
Harvard University, 2020
2020
A Genetic Limiter Device: Investigation Into Protein Degradation Rates as a Basis for Biological Network Design
A Glieberman
Brown University, 2009
2009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–8